Meridian Bioscience News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.04.16	Meridian Bioscience bringt neuen Molekulartest fur die Erkennung des Bakteriums Mycoplasma pneumoniae auf den Markt. (GlobeNewswire)
27.01.16	Meridian Bioscience Inc. Earnings Climb 13% In Q1 (RTTNews)
27.01.16	Neuer Malaria-Test, illumigene® Malaria, setzt neue Massstäbe für die Diagnose (GlobeNewswire)
26.01.16	New Malaria Test, illumigene® Malaria, Sets a New Gold Standard for Diagnosis (GlobeNewswire)
09.09.15	Meridian Project FY16 EPS In A Range Of $0.86 To $0.90 (RTTNews)
23.07.15	EARNINGS SUMMARY: Details of Meridian Bioscience Inc. Q3 Earnings Report (RTTNews)
21.05.15	Meridian Bioscience Europe Launches New Molecular Tests for the Detection of Herpes Simplex Virus Type 1 and Type 2 (Businesswire)
02.12.14	Meridian Life Granted SBIR II From Centers For Disease Control And Prevention (RTTNews)
02.09.14	Meridian Bioscience Reiterates FY14 Guidance; Sees "Modest" Growth In FY15 (RTTNews)
22.01.14	Meridian Q1 Earnings Decline In Line With Estimates; Confirms FY14 Outlook (RTTNews)
16.01.14	Meridian Bioscience Sees Q1 Results Below Consensus; Reaffirms FY14 Outlook (RTTNews)
09.09.13	Meridian Bioscience Provides FY14 Outlook, Reaffirms FY13 Guidance - Quick Facts (RTTNews)
12.11.09	Meridian Bioscience Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance (Businesswire)
30.09.09	Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease (Businesswire)
16.07.09	Meridian Bioscience Reports Record Sales and Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2009 Guidance, and Comments on Timing of Fiscal 2010 Guidance (Businesswire)
03.06.09	Meridian Bioscience Receives FDA Clearance for New Rapid Campylobacter Test (Businesswire)
22.01.09	Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2009 Guidance (Businesswire)
15.01.09	Meridian Bioscience, Inc. Announces Preliminary First Quarter Operating Results and Revises Fiscal 2009 Revenue Guidance (Businesswire)
02.12.08	Meridian Bioscience Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement (Businesswire)
12.10.07	Meridian Life Science Announces USDA/APHIS EC 1774:2002 Approval for Its Viral Antigens Production Facility (Businesswire)
28.08.07	Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine (Businesswire)
14.08.06	Meridian Partners with Merck KGaA/Germany to Develop New Products (Businesswire)
09.08.06	Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2007 and Reaffirms Fiscal 2006 Guidance (Businesswire)
20.07.06	Meridian Bioscience Reports Record Operating Results, Declares Regular Cash Dividend, Reaffirms Higher Fiscal 2006 Guidance, and Comments on Fiscal 2007 Outlook (Businesswire)
06.07.06	Meridian Bioscience Announces Its Inclusion in the New NASDAQ Global Select Market - The Market With the Highest Initial Listing Standards in the World - (Businesswire)
26.06.06	FORTUNE Small Business Ranks America's Fastest-Growing Small Companies (Businesswire)
15.06.06	Meridian Bioscience to Present at the InvesTristate Regional Public Company Investment Conference (Businesswire)
12.06.06	Meridian Bioscience Receives FDA CLIA Waiver Status for Stomach Ulcer Test (Businesswire)
23.09.05	Meridian Bioscience to Present at UBS Global Life Science Conference (Businesswire)
09.05.05	Meridian Bioscience Announces Third Partial Redemption of Its 7% Conve (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	96.64	3.03 %	K V
Sonova Hldg	321.00	0.72 %	K V
CieFinRichemont	177.90	0.42 %	K V
Logitech Intl	90.60	0.38 %	K V
Swiss Re	140.45	0.25 %	K V
Holcim	91.66	-0.30 %	K V
ABB	49.91	-0.46 %	K V
Alcon	83.64	-0.50 %	K V
Geberit	509.80	-0.55 %	K V
Lonza Grp	585.00	-0.98 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Meridian Bioscience Inc.

Aktien Top/Flop

Meistgelesene Nachrichten